Medicine Man Technologies (MDCL) Stock Price, News & Analysis

Company Overview

Medicine Man Technologies, Inc. provides advisory and consulting services related to cannabis cultivation. It offers consulting, application and licensing, cultivation technology, dispensary operations, facility design and training services. The firm products include Nutrients, The Big Tomato and Three A Light. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.

Key Stats

• Today's Range: $0.01 to $0.05
• 50-Day Range: $0.01 to $1.90
• 52-Week Range: $1.05 to $4.05
• Volume: 68,033 shs
• Average Volume: 84,948 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MDCL Stock Analysis - Frequently Asked Questions

How have MDCL shares performed this year?

Medicine Man Technologies' stock was trading at $0.6097 on January 1st, 2024. Since then, MDCL stock has decreased by 93.4% and is now trading at $0.04.
View the best growth stocks for 2024 here.

How do I buy shares of Medicine Man Technologies?

Shares of MDCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Medicine Man Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicine Man Technologies investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Curaleaf (CURLF), Charlotte's Web (CWBHF), Organigram (OGI), Trees (CANN) and Cronos Group (CRON).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Business Services
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:MDCL
• Previous Symbol: NASDAQ:MDCL
• CUSIP: N/A
• CIK: 1622879
• Web: medicinemantechnologies.com
• Phone: (303) 371-0387
• Fax: N/A
• Employees: 390
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A